Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...

Jury Rules Bayer (Monsanto) Must Pay $100M in Trial Over PCBs in Washington School. Bayer has been ordered to pay $100 million to four individuals who claim they suffered health issues due to exposure ...

Scientists have warned that blueberries could be wiped out a fungus rapidly-spreading worldwide. Caused by a two different strains of fungus, the disease appears as a white powdery mildew on ...

While many traditional Chinese/herbal medicine consumers are drawn to the fungus for its supposed health benefits, my interest lies in a darker side of its harvest: the deadly relationship between ...

Bayer argues PCB levels were safe, blames school for ignoring warnings Previous trials resulted in over $1.5 billion in verdicts Jan 14 (Reuters) - A Washington jury on Tuesday ordered Bayer ...

The gameplay trailer for Street Fighter 6's next fighter Mai Shiranui has been revealed Mai Shiranui will be released on February 5 Mai's will be the second guest character to be added to a Street ...

HONG KONG, Jan 14 (Reuters) - Country Garden (2007.HK), opens new tab said it expected to post a narrower annual loss in 2024 as the embattled developer looks to revive its business and stave off ...

A fungus causing powdery mildew in blueberries has spread from the U.S. to continents like Europe and Asia, threatening crops and increasing fungicide dependence. NC State researchers found that ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...

An old-fashioned turf battle is erupting over the transfer of a fighter squadron from the District of Columbia to Maryland with critics worried this leaves the nation’s capital dangerously ...